Abstract:Purpose: This study aimed to summarize the clinical characteristics and outcomes of Legionella pneumophila (L. pneumophila) pneumonia to assist clinicians in accurately and early identifying this disease. The findings provide evidence to guide decision-making for L. pneumophila infection and improve treatment success rates. Patients and methods: A retrospective analysis of clinical data was conducted on 19 patients diagnosed with L. pneumophila infection at our hospital using Metagenomic next-generation sequencing (mNGS). Results: The study included 16 male and 3 female participants, with an average age of 59.5±16.2 years. The majority of participants were immunocompromised (13/19). The most common symptoms included fever (n=11) with a median peak value of 39.5?, cough (n = 15), expectoration (n = 14), dyspnea (n = 10), poor appetite (n = 9), fatigue (n = 8), and headache (n = 3). Elevated levels of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were observed in all patients, while procalcitonin (PCT) and lactate dehydrogenase (LDH) levels were significantly higher in the severe group compared to the non-severe group. Lymphocyte count levels were also significantly lower in the severe group (P<0.05). Common CT manifestations included flake high-density shadows (n = 17), pleural effusion (n = 11), consolidation (n = 4), ground-glass exudation (n = 4), and bronchial inflation signs (n = 3). The most prevalent underlying diseases were hypertension (n = 9), diabetes (n = 8), AIDS (n = 6), COPD (n = 5), and malignancies (n = 3). Common complications included acute liver injury (n=7), acute respiratory failure (n=6), electrolyte disorders (n=5), sepsis (n=3), MODS (n=2), and ARDS (n=1). The majority of patients received treatment with quinolones (16/19), with six patients requiring mechanical ventilation therapy. Tragically, 2 patients in the severe pneumonia group succumbed to sepsis and multiple organ failure. Conclusion: L. pneumophila pneumonia is an acute respiratory infection. If not promptly diagnosed, patients may develop severe pneumonia, multiorgan failure, or face fatal outcomes. mNGS can be used for rapid and accurate diagnosis of L. pneumophila infections, thereby improving treatment outcomes. Early initiation of quinolones or combination therapy with other medications has demonstrated a significant therapeutic benefit for patients with L. pneumophila pneumonia.

Community-acquired Legionella pneumonia in elderly patients: clinical characteristics and outcome

Chest Radiographic Characteristics of Community-Acquired Legionella Pneumonia in the Elderly.

Clinical analysis of 42 elderly patients with pulmonary cryptococcosis

Clinical and Image Characteristics of Hospital Acquired Pneumonia in the Elderly

Clinical Analysis of Community Acquired Pneumonia in the Elderly Patients

Comparison of clinical characteristics and outcomes of pyogenic liver abscess patients < 65 years of age versus ≥ 65 years of age

Clinical features and prognostic factors of elderly patients with severe community-acquired pneumonia

Clinical Analysis of Elderly Patients with Healthcare-Associated Pneumonia

Common Syndromes of Community Acquired Pneumonia and Analysis on Characteristics of Elderly Patients

2206. Patterns of Care and Outcomes in Elderly Patients Hospitalized with Community-acquired Pneumonia in the United States

Comparative study of Legionella pneumonia and other nosocomial-acquired pneumonia]

The Clinical Feature and Countermeasures of Hospital-Acquired Pneumonia in Non-Surgical Treatment Elderly Inpatients with Lung Cancer

Evaluation of clinical characteristics of Legionella pneumophila pneumonia diagnosed by metagenomic Next-Generation Sequencing:A retrospective study

[A Multicenter Prospective Cohort Study on Risk Factors for Hospital-Acquired Pneumonia in the Elderly].

Research progress of Legionella Pneumonia

Effect of Poor Nutritional Status and Comorbidities on the Occurrence and Outcome of Pneumonia in Elderly Adults

Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients

Comparative analysis of pathogens in lower respiratory tract infections between elderly patients and young patients

Analysis of the Medication of Elderly Patients with Community-acquired Pneumonia in Our Hospital from 2010 to 2012

Atypical pathogens in adult patients admitted with community-acquired pneumonia

Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients